SpinChip Hs-cTnI Multisite Precision (HEAT-1)
Multisite Precision Study for the SpinChip High-sensitivity Cardiac Troponin I (SpinChip Hs-cTnI) Test
Sponsor: Aurevia
This observational or N/A phase trial investigates Acute Myocardial Infarction (AMI) and is currently completed. Aurevia leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
2 versions recorded-
Jun 2025 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Mar 2025 — Jun 2025 [monthly]
Recruiting
First recorded
Feb 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aurevia
- SpinChip Diagnostics ASA
For direct contact, visit the study record on ClinicalTrials.gov .